Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001477932-25-005077
Filing Date
2025-07-16
Accepted
2025-07-15 20:11:28
Documents
39
Period of Report
2025-03-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-K agtx_10k.htm   iXBRL 10-K 521912
2 CERTIFICATION agtx_ex311.htm EX-31.1 13093
3 CERTIFICATION agtx_ex312.htm EX-31.2 13149
4 CERTIFICATION agtx_ex321.htm EX-32.1 4710
5 COMPENSATION RECOUPMENT POLICY agtx_ex971.htm EX-97.1 42692
11 agtx_10kimg2.jpg GRAPHIC 4537
12 agtx_10kimg1.jpg GRAPHIC 2460
  Complete submission text file 0001477932-25-005077.txt   2159347

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA agtx-20250331.xsd EX-101.SCH 18927
7 XBRL TAXONOMY EXTENSION LABEL LINKBASE agtx-20250331_lab.xml EX-101.LAB 137132
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE agtx-20250331_cal.xml EX-101.CAL 27737
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE agtx-20250331_pre.xml EX-101.PRE 103676
10 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE agtx-20250331_def.xml EX-101.DEF 36069
42 EXTRACTED XBRL INSTANCE DOCUMENT agtx_10k_htm.xml XML 157871
Mailing Address 32932 PACIFIC COAST HIGHWAY #14-254 DANA POINT CA 92629
Business Address 32932 PACIFIC COAST HIGHWAY #14-254 DANA POINT CA 92629 321-229-2014
Agentix Corp. (Filer) CIK: 0001603345 (see all company filings)

EIN.: 462876282 | State of Incorp.: NV | Fiscal Year End: 0331
Type: 10-K | Act: 34 | File No.: 000-55383 | Film No.: 251126014
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)